Venture Capital 101: How the Money Actually Works | 6:00-7:00pm ET
Session Summary
For scientists considering how to translate a research discovery into a startup, venture capital can become an important source of funding, but the way investors evaluate opportunities can feel unfamiliar. This session introduces how venture capital works, where investment capital comes from, how funds generate returns, and why those mechanics influence which science-driven ventures investors choose to support.
Participants will learn how capital flows from limited partners into venture funds and then into startups; how management fees, carried interest, and power-law economics shape fund performance; and how financing typically progresses from pre-seed through Series A. The session will also explore why venture investors pass on the vast majority of opportunities they review, why a scientifically promising idea may not necessarily be considered investable, and what venture capital is and is not well suited to fund compared with grants, non-dilutive funding, and other sources of capital.

This 60-minute webinar will include a concise primer on key concepts, a moderated fireside conversation with a guest investor from an established early-stage venture fund, and audience Q&A. Participants will also receive a one-page resource sheet highlighting key concepts and resources for further learning.
Join live, watch later. The best experience happens live: join the conversation, ask questions, and engage with the instructor in real time. Register now to secure your spot and receive access to the recording, giving you the flexibility to tune in live, catch up later, or revisit the content anytime.
Learning Objectives
By the end of this session, participants will be able to:
-
Describe how capital flows from limited partners through venture funds to early-stage companies.
-
Explain how venture capital funds generate returns, including the roles of management fees, carried interest, and power-law economics.
-
Distinguish among common stages of early venture financing, including pre-seed, seed, and Series A.
-
Identify factors that influence why venture investors pursue or pass on early-stage opportunities.
-
Explain how a venture fund’s return expectations shape the types of opportunities it can invest in.
-
Compare venture capital with grants, non-dilutive funding, and other financing options to determine when venture investment may or may not be appropriate for a science-driven startup.
Intended Audience
This session is designed for:
- STEM researchers who want a practical introduction to how venture capital works.
- Researchers considering startup formation or venture funding for a science-driven opportunity.
- Scientists interested in understanding how investors make funding decisions and how venture capital compares with other sources of support.
No prior experience in venture capital, finance, startups, or commercialization is required.
Meet the Instructor

Alex Fang is Co-Founder and Director of RoundZero, a philanthropic investment initiative designed to help early-stage deep-tech founders bridge the gap between scientific discovery and scalable impact. A serial entrepreneur, social impact leader, startup mentor, and investor, Fang brings nearly two decades of experience across for-profit and nonprofit social impact. He co-founded Surf For Life, an international development organization that has helped more than 600,000 children access clean water, shelter, and education, and his most recent exit from a company he co-founded culminated in a $43 million acquisition. His work has also included leading innovation partnerships at a U.S. Department of Energy climate-tech accelerator and serving on National Science Foundation panels supporting the domestic innovation economy. Fang’s experience across venture development, startup mentorship, impact investing, philanthropy, and sustainable finance positions him to help scientists understand how investors and partners evaluate research-driven ventures.
Pricing
Designed as a four-part learning journey, this course builds concepts and skills across each session. Participants in the PhD to VC: Translating Scientific Breakthroughs into Investable Ventures Course may register for the full four-session course or for individual sessions. Each session is designed to provide value as a standalone program; however, the course builds progressively from venture capital fundamentals and research commercialization to investor evaluation and pathways for engaging in the venture ecosystem.
Participation in the full course is recommended for those seeking to achieve the complete set of learning objectives and develop a more comprehensive understanding of how scientific discoveries move toward venture investment and commercialization. Bundled course pricing offers the best value.
| Category | Session Rate | Series Rate |
|---|---|---|
Member |
$125 |
$395 |
Member: Student* |
$65 |
$195 |
To earn a Certificate of Participation, register by January 25, 2027, and attend all four sessions live in full. Registration remains open after the series begins and includes access to all recordings for one year, but late registrants are not eligible to receive a certificate.
This course is being offered exclusively for Academy members. Nonmembers can purchase membership directly during event registration in order to participate.
*Our Student community includes Postdocs and Fellows
From Lab to Market: The Deep Tech Landscape Today | 6:00-7:00pm ET
Session Summary
Transforming a scientific discovery into a viable company requires more than strong research. Promising technologies can stall between the lab and the market when they lack the funding, partnerships, commercial validation, or infrastructure needed to advance. This session introduces the pathway from research discovery to early-stage venture creation and examines the critical transition points along the way.
Participants will explore how a scientific innovation can move from invention disclosure and technology transfer through licensing, non-dilutive funding, incubators and accelerators, and ultimately to institutional investment. The discussion will also consider the current deep tech landscape, including sectors attracting investor interest such as biotechnology, artificial intelligence, climate technology, advanced materials, and quantum technologies, as well as emerging sources of capital including philanthropic and impact-oriented funding.

This 60-minute webinar will include a concise primer on key concepts, a moderated fireside conversation with a scientist-founder, deep tech investor, or technology transfer leader with experience bringing research-driven technologies toward market, and audience Q&A. Participants will also receive a one-page resource sheet highlighting key concepts and resources for further learning.
Join live, watch later. The best experience happens live: join the conversation, ask questions, and engage with the instructor in real time. Register now to secure your spot and receive access to the recording, giving you the flexibility to tune in live, catch up later, or revisit the content anytime.
Learning Objectives
By the end of this session, participants will be able to:
- Describe the major stages involved in translating a scientific discovery from the laboratory toward commercialization.
- Explain the roles of invention disclosure, technology transfer, licensing, incubators, and early institutional investment in the lab-to-market process.
- Identify common barriers that contribute to the “valley of death” between scientific discovery and commercial adoption.
- Compare funding sources available at different stages of commercialization, including grants, Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding, foundation support, philanthropic or impact-oriented capital, and venture investment.
- Identify current areas of investor interest across the deep tech landscape.
- Map their own research or technology onto the lab-to-market pathway and identify funding sources that may be appropriate at its current stage.
Intended Audience
This session is designed for:
- STEM researchers exploring how scientific discoveries move from the laboratory toward commercialization.
- Researchers considering technology transfer, licensing, startup formation, or other lab-to-market pathways.
- Scientists interested in understanding funding options and current investment activity across deep tech sectors.
No prior experience in venture capital, finance, startups, or commercialization is required.
Meet the Instructor

Alex Fang is Co-Founder and Director of RoundZero, a philanthropic investment initiative designed to help early-stage deep-tech founders bridge the gap between scientific discovery and scalable impact. A serial entrepreneur, social impact leader, startup mentor, and investor, Fang brings nearly two decades of experience across for-profit and nonprofit social impact. He co-founded Surf For Life, an international development organization that has helped more than 600,000 children access clean water, shelter, and education, and his most recent exit from a company he co-founded culminated in a $43 million acquisition. His work has also included leading innovation partnerships at a U.S. Department of Energy climate-tech accelerator and serving on National Science Foundation panels supporting the domestic innovation economy. Fang’s experience across venture development, startup mentorship, impact investing, philanthropy, and sustainable finance positions him to help scientists understand how investors and partners evaluate research-driven ventures.
Pricing
Designed as a four-part learning journey, this course builds concepts and skills across each session. Participants in the PhD to VC: Translating Scientific Breakthroughs into Investable Ventures Course may register for the full four-session course or for individual sessions. Each session is designed to provide value as a standalone program; however, the course builds progressively from venture capital fundamentals and research commercialization to investor evaluation and pathways for engaging in the venture ecosystem.
Participation in the full course is recommended for those seeking to achieve the complete set of learning objectives and develop a more comprehensive understanding of how scientific discoveries move toward venture investment and commercialization. Bundled course pricing offers the best value.
| Category | Session Rate | Series Rate |
|---|---|---|
Member |
$125 |
$395 |
Member: Student* |
$65 |
$195 |
To earn a Certificate of Participation, register by January 25, 2027, and attend all four sessions live in full. Registration remains open after the series begins and includes access to all recordings for one year, but late registrants are not eligible to receive a certificate.
This course is being offered exclusively for Academy members. Nonmembers can purchase membership directly during event registration in order to participate.
*Our Student community includes Postdocs and Fellows
Inside the Deal: Dealflow and How Investors Judge Science Startups | 6:00-7:00pm ET
Session Summary
Once a scientific venture begins seeking investment, it enters a highly selective process in which investors may review hundreds or thousands of opportunities to identify a small number worth pursuing. This session examines how early-stage investors source science startups, move opportunities through the investment funnel, and decide which ventures merit deeper diligence or funding.
Participants will learn where investment opportunities come from, including professional networks, universities, founders, and scouts, and why scientists themselves can be valuable sources of new ventures. The session will introduce the core areas investors assess during diligence, including the founding team, technology, market opportunity, timing, and intellectual property (IP), as well as common red flags that can stop a deal from advancing. Participants will also gain a plain-language introduction to term sheets and explore how scientific expertise can strengthen technical diligence and investment decision-making.

This 60-minute webinar will include a concise primer on key concepts, a moderated fireside conversation with an early-stage investor from a deep tech seed fund, and audience Q&A. The guest may also walk through how they would assess an example science startup. Participants will receive a one-page resource sheet highlighting key concepts and resources for further learning.
Join live, watch later. The best experience happens live: join the conversation, ask questions, and engage with the instructor in real time. Register now to secure your spot and receive access to the recording, giving you the flexibility to tune in live, catch up later, or revisit the content anytime.
Learning Objectives
By the end of this session, participants will be able to:
- Describe how early-stage investors source and screen potential science and deep tech investments.
- Explain how opportunities move through the investment funnel from initial review to deeper diligence and potential investment.
- Identify key factors investors assess when evaluating an early-stage science venture, including team, technology, market, timing, and intellectual property.
- Recognize common red flags that can prevent an investment opportunity from advancing.
- Describe the basic purpose and components of a venture capital term sheet.
- Apply a team, technology, market, and timing framework to assess the investment potential of an early-stage science venture.
Intended Audience
This session is designed for:
- STEM researchers who want to understand how investors source, screen, and evaluate science-driven ventures.
- Founders or aspiring founders preparing to engage with early-stage investors.
- Scientists interested in applying their technical expertise to venture diligence or investment evaluation.
No prior experience in venture capital, finance, startups, or commercialization is required.
Meet the Instructor

Alex Fang is Co-Founder and Director of RoundZero, a philanthropic investment initiative designed to help early-stage deep-tech founders bridge the gap between scientific discovery and scalable impact. A serial entrepreneur, social impact leader, startup mentor, and investor, Fang brings nearly two decades of experience across for-profit and nonprofit social impact. He co-founded Surf For Life, an international development organization that has helped more than 600,000 children access clean water, shelter, and education, and his most recent exit from a company he co-founded culminated in a $43 million acquisition. His work has also included leading innovation partnerships at a U.S. Department of Energy climate-tech accelerator and serving on National Science Foundation panels supporting the domestic innovation economy. Fang’s experience across venture development, startup mentorship, impact investing, philanthropy, and sustainable finance positions him to help scientists understand how investors and partners evaluate research-driven ventures.
Pricing
Designed as a four-part learning journey, this course builds concepts and skills across each session. Participants in the PhD to VC: Translating Scientific Breakthroughs into Investable Ventures Course may register for the full four-session course or for individual sessions. Each session is designed to provide value as a standalone program; however, the course builds progressively from venture capital fundamentals and research commercialization to investor evaluation and pathways for engaging in the venture ecosystem.
Participation in the full course is recommended for those seeking to achieve the complete set of learning objectives and develop a more comprehensive understanding of how scientific discoveries move toward venture investment and commercialization. Bundled course pricing offers the best value.
| Category | Session Rate | Series Rate |
|---|---|---|
Member |
$125 |
$395 |
Member: Student* |
$65 |
$195 |
To earn a Certificate of Participation, register by January 25, 2027, and attend all four sessions live in full. Registration remains open after the series begins and includes access to all recordings for one year, but late registrants are not eligible to receive a certificate.
This course is being offered exclusively for Academy members. Nonmembers can purchase membership directly during event registration in order to participate.
*Our Student community includes Postdocs and Fellows
From Bench to Cap Table: How Scientists Break into Venture | 6:00-7:00pm ET
Event Summary
Scientists can engage with venture capital in many ways, from advising on technical diligence to founding companies or becoming investors themselves. This session explores the range of roles available to researchers and PhD-trained scientists, including opportunities to gain venture experience while remaining active in science.
Participants will learn about roles such as technical diligence advisor, venture scout, entrepreneur-in-residence, venture partner, angel or syndicate member, as well as full-time pathways through venture fellowships and associate roles. The discussion will examine what venture firms value in scientists, how research expertise can translate into investment work, and practical first steps for building experience, networks, and credibility in the venture ecosystem.

This 60-minute webinar will include a concise primer on key concepts, a moderated fireside conversation with a PhD-trained investor who has transitioned from scientific research into venture capital, and audience Q&A. Participants will also receive a one-page resource sheet highlighting key concepts, career pathways, and resources for further engagement with the venture community.
Join live, watch later. The best experience happens live: join the conversation, ask questions, and engage with the instructor in real time. Register now to secure your spot and receive access to the recording, giving you the flexibility to tune in live, catch up later, or revisit the content anytime.
Learning Objectives
By the end of this session, participants will be able to:
- Identify roles scientists can play in the venture ecosystem, including advisor, scout, entrepreneur-in-residence, venture partner, founder, and investor.
- Distinguish between part-time or advisory opportunities and full-time career pathways into venture capital.
- Explain how scientific training and research experience can contribute to venture sourcing, technical diligence, and investment decision-making.
- Describe common pathways into venture capital, including fellowships, associate roles, scouting, advising, and company formation.
- Assess which venture roles may align with their own experience, interests, and career goals.
- Identify two or three concrete steps they can take to begin engaging with the venture ecosystem.
Intended Audience
This session is designed for:
- STEM researchers interested in exploring careers or experiential opportunities in venture capital.
- Scientists considering roles such as venture scout, technical advisor, founder, or investor.
- Researchers who want practical guidance on how to begin building experience and networks in the venture ecosystem.
No prior experience in venture capital, finance, startups, or commercialization is required.
Meet the Instructor

Alex Fang is Co-Founder and Director of RoundZero, a philanthropic investment initiative designed to help early-stage deep-tech founders bridge the gap between scientific discovery and scalable impact. A serial entrepreneur, social impact leader, startup mentor, and investor, Fang brings nearly two decades of experience across for-profit and nonprofit social impact. He co-founded Surf For Life, an international development organization that has helped more than 600,000 children access clean water, shelter, and education, and his most recent exit from a company he co-founded culminated in a $43 million acquisition. His work has also included leading innovation partnerships at a U.S. Department of Energy climate-tech accelerator and serving on National Science Foundation panels supporting the domestic innovation economy. Fang’s experience across venture development, startup mentorship, impact investing, philanthropy, and sustainable finance positions him to help scientists understand how investors and partners evaluate research-driven ventures.
Pricing
Designed as a four-part learning journey, this course builds concepts and skills across each session. Participants in the PhD to VC: Translating Scientific Breakthroughs into Investable Ventures Course may register for the full four-session course or for individual sessions. Each session is designed to provide value as a standalone program; however, the course builds progressively from venture capital fundamentals and research commercialization to investor evaluation and pathways for engaging in the venture ecosystem.
Participation in the full course is recommended for those seeking to achieve the complete set of learning objectives and develop a more comprehensive understanding of how scientific discoveries move toward venture investment and commercialization. Bundled course pricing offers the best value.
| Category | Session Rate | Series Rate |
|---|---|---|
Member |
$125 |
$395 |
Member: Student* |
$65 |
$195 |
To earn a Certificate of Participation, register by January 25, 2027, and attend all four sessions live in full. Registration remains open after the series begins and includes access to all recordings for one year, but late registrants are not eligible to receive a certificate.
This course is being offered exclusively for Academy members. Nonmembers can purchase membership directly during event registration in order to participate.
*Our Student community includes Postdocs and Fellows